Counsel to numerous biopharmaceutical clients in various stages of development.Advised numerous clients on securities offers of equity and debt.Advising public companies and their boards of directors across a variety of industries on strategic decisions, risk oversight, governance, and ESG matters.Counsel to various public companies facing proxy contests and shareholders activists.Represented clients in highly regulated industries, including health care and life sciences and financial services in numerous acquisitions, sales, and investment transactions.